noctuRNA Therapeutics
Biotechnology Research
Barcelona, Es
5 employees
- Employees
- 5
noctuRNA Therapeutics Overview
- Headquarters
- Barcelona, Es
- Website
- nocturnatx.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2022
- Funding
- 711.9K
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About noctuRNA Therapeutics
noctuRNA Therapeutics is a spin-off from Universitat Pompeu Fabra. noctuRNA Tx has built a patented RNA-based drug platform that enables the generation of novel candidate therapeutical molecules within 2 to 4 weeks. This drug platform is based on artificial circular RNA molecules (circRNA) that efficiently disrupt pathogenic or aberrant RNA secondary structures present in several diseases. We have developed a first-in-class therapeutic approach to tackle some of the world's most intractable diseases.
noctuRNA Therapeutics Contact Details
- People in AeroLeads
- 3
noctuRNA Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Miriam Corredor Sánchez | CEO at Nocturna Therapeutics - Phd | Terrassa, Catalonia, Spain |
View
|
| Mònica Mendoza Blanco, Phd | Scientist - Molecular Biologist - Phd | Barcelona, Catalonia, Spain |
View
|
| Juana Diez | Professor in Virology, Department |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to noctuRNA Therapeutics
Leitat Technological Center
Research Services
Nanological
Medical Equipment Manufacturing
Miramoon Pharma
Biotechnology Research
Point Pressure
Medical Equipment Manufacturing
AFFIRMA BIOTECH SL
Biotechnology Research
Moirai Biodesign
Biotechnology Research
SUCCIPRO
Biotechnology Research
Telomere Therapeutics
Biotechnology Research
Ivestatin Therapeutics
Pharmaceutical Manufacturing
Nema-Health
Biotechnology Research